Roderick Hafner
Director/Board Member bei Circassia Pharma Ltd.
Profil
Roderick Peter Hafner is currently a Director at Circassia Pharma Ltd.
He previously held positions as a Director at Adiga Life Sciences, Inc., Principal at Wyeth LLC and Procter & Gamble Co., Head-Project Management at Provalis Plc and Cortecs International Ltd., Vice President-Research & Development at Circassia Ltd., Vice President-Development at Powderject Pharmaceuticals Plc, and Principal at Optinose AS.
He also served as Senior Vice President-Research & Development at Niox Group Plc from 2007 to 2020.
Hafner received a doctorate from the University of Cambridge in 1990 and an undergraduate degree from The University of Edinburgh.
Aktive Positionen von Roderick Hafner
| Unternehmen | Position | Beginn |
|---|---|---|
Circassia Pharma Ltd.
 Circassia Pharma Ltd. Medical/Nursing ServicesHealth Services Circassia Pharma Ltd. is a biopharmaceutical company, which engages as a subsidiary of Circassia Pharmaceuticals plc. It focuses on the research and development of respiratory disease and allergy products. The company was founded on October 26, 2007 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 29.10.2007 |
Ehemalige bekannte Positionen von Roderick Hafner
| Unternehmen | Position | Ende |
|---|---|---|
| NIOX GROUP PLC | Chief Tech/Sci/R&D Officer | 01.04.2020 |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Corporate Officer/Principal | - |
| Cortecs International Ltd. | Corporate Officer/Principal | - |
Adiga Life Sciences, Inc.
 Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Director/Board Member | - |
Ausbildung von Roderick Hafner
| University of Cambridge | Doctorate Degree |
| The University of Edinburgh | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| NIOX GROUP PLC | Health Services |
| Private Unternehmen | 8 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| Provalis Plc | Health Technology |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
Optinose AS
 Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | Health Technology |
| Cortecs International Ltd. | Miscellaneous |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Health Technology |
Circassia Pharma Ltd.
Circassia Pharma Ltd. Medical/Nursing ServicesHealth Services Circassia Pharma Ltd. is a biopharmaceutical company, which engages as a subsidiary of Circassia Pharmaceuticals plc. It focuses on the research and development of respiratory disease and allergy products. The company was founded on October 26, 2007 and is headquartered in Oxford, the United Kingdom. | Health Services |
